GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
ROCE(%) | 67.64 | 46.49 | 38.06 | 37.72 | 27.74 |
What is the latest Return on Capital Employed (ROCE) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Return on Capital Employed (ROCE) |
---|---|
Mar2025 | 67.64 |
Mar2024 | 46.49 |
Mar2023 | 38.06 |
Mar2022 | 37.72 |
Mar2021 | 27.74 |
How is Return on Capital Employed (ROCE) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Return on Capital Employed (ROCE) | % Change | |
---|---|---|---|
Mar2025 | 67.64 | 45.49 | |
Mar2024 | 46.49 | 22.15 | |
Mar2023 | 38.06 | 0.90 | |
Mar2022 | 37.72 | 35.98 | |
Mar2021 | 27.74 | - |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹54,924.6 Cr | -1.2% | -2.3% | 27.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -1.2% |
-2.3% |
27.2% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses